Skip to main content

Akebia Therapeutics, Inc 10-Q for FY2025 Q2

Akebia Therapeutics, Inc. (AKBA)

10-Q 2025-08-07 For: 2025-06-30
View Original
Added on April 11, 2026

About this 10-Q

Akebia Therapeutics, Inc filed this 10-Q on August 7, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$62.47M
up 43.1% from $43.65M a year earlier
Net income
$247K
compared with a net loss of $8.58M a year earlier
Diluted EPS
$0.00
compared with -$0.04 a year earlier